8VP1 Stock Overview
Engages in the health data and point-of-care technologies business in Canada. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Avricore Health Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.038 |
52 Week High | CA$0.20 |
52 Week Low | CA$0.015 |
Beta | -2.07 |
1 Month Change | 11.76% |
3 Month Change | -63.46% |
1 Year Change | -60.62% |
3 Year Change | -59.14% |
5 Year Change | 660.00% |
Change since IPO | -97.05% |
Recent News & Updates
Recent updates
Shareholder Returns
8VP1 | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | -2.6% | 1.1% | 3.0% |
1Y | -60.6% | -23.4% | 13.2% |
Return vs Industry: 8VP1 underperformed the German Healthcare Services industry which returned -22.2% over the past year.
Return vs Market: 8VP1 underperformed the German Market which returned 13.1% over the past year.
Price Volatility
8VP1 volatility | |
---|---|
8VP1 Average Weekly Movement | 27.0% |
Healthcare Services Industry Average Movement | 6.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8VP1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8VP1's weekly volatility has increased from 19% to 27% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | n/a | Hector Bremner | avricore.com |
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018.
Avricore Health Inc. Fundamentals Summary
8VP1 fundamental statistics | |
---|---|
Market cap | €4.41m |
Earnings (TTM) | €69.05k |
Revenue (TTM) | €3.16m |
63.8x
P/E Ratio1.4x
P/S RatioIs 8VP1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8VP1 income statement (TTM) | |
---|---|
Revenue | CA$4.72m |
Cost of Revenue | CA$2.93m |
Gross Profit | CA$1.79m |
Other Expenses | CA$1.69m |
Earnings | CA$103.13k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.001 |
Gross Margin | 37.97% |
Net Profit Margin | 2.19% |
Debt/Equity Ratio | 0% |
How did 8VP1 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/21 20:58 |
End of Day Share Price | 2025/01/21 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Avricore Health Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|